NCT03360851View on ClinicalTrials.gov

DiagNostic Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired Pneumonia

NATerminatedINTERVENTIONAL
Enrollment

3,555

Participants

Timeline

Start Date

November 27, 2017

Primary Completion Date

June 24, 2020

Study Completion Date

March 1, 2021

Conditions
Community-acquired Pneumonia
Interventions
DIAGNOSTIC_TEST

low-dose CT

see arm/group description

DIAGNOSTIC_TEST

PoC-PCR

see arm/group description

Trial Locations (7)

Unknown

Noordwest Ziekenhuisgroep, Alkmaar

Amphia Ziekenhuis, Breda

Catharina Ziekenhuis, Eindhoven

Ter Gooi Ziekenhuis, Hilversum

University Medical Center, Utrecht

Maxima MC, Veldhoven

Langeland Ziekenhuis, Zoetermeer

Sponsors

Collaborators (1)

BioMérieux
All Listed Sponsors
collaborator

BioMérieux

INDUSTRY

lead

MJM Bonten

OTHER

NCT03360851 - DiagNostic Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired Pneumonia | Biotech Hunter | Biotech Hunter